Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Clinical Case Reports|May 11, 2018
Ablation of parahisian premature ventricular extrasystoles by subtricuspid retrograde approach using inverted catheter technique: back to the anatomyBasar Candemir, Veysel Duzen, Firat Coskun, et al.Indian Pacing and Electrophysiology Journal|March 2, 2019
Late elimination of challenging idiopathic ventricular arrhythmias originating from left ventricular summit by anatomical ablationBasar Candemir, Emir Baskovski, Veysel Duzen, et al.Echocardiography (Mount Kisco, N.Y.)|January 15, 2015
Effects of Hemodialysis on Tei Index: Comparison between Flow Doppler and Tissue Doppler ImagingDemet Menekse Gerede, Sibel Turhan, Cansin Tulunay Kaya, et al.Mayo Clinic Proceedings|August 4, 2007
Relationship between angiotensin-converting enzyme gene polymorphism and severity of aortic valve calcificationFatih S Ertas, Taner Hasan, Cagdas Ozdol, et al.Coronary Artery Disease|June 29, 2011
Anticalcifying nanoparticle antibody titer is an independent risk factor for coronary artery calcificationCansin Tulunay Kaya, Fatih Sinan Ertas, Taner Hasan, et al.Journal of the American Heart Association|February 9, 2018
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) TrialTymon Pol, Claes Held, Johan Westerbergh, et al.European Heart Journal|February 25, 2014
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trialSigrun Halvorsen, Dan Atar, Hongqiu Yang, et al.Circulation|June 25, 2015
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialAlvaro Avezum, Renato D Lopes, Phillip J Schulte, et al.Journal of the American Heart Association|December 3, 2015
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialMeena P Rao, Sigrun Halvorsen, Daniel Wojdyla, et al.Lancet (London, England)|October 6, 2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialRenato D Lopes, Sana M Al-Khatib, Lars Wallentin, et al.Pageof 8